Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Size: px
Start display at page:

Download "Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)"

Transcription

1 Columbia-Suicide Severity Rating Scale Baseline ( ) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) Notes to Readers This implementation guide is intended to be used with other CDISC User Guides for specific Therapeutic/Disease Areas and follows the CDISC Study Data Tabulation Model Implementation Guide for Human Clinical trials. Revision History Date Version Summary of Changes Columbia-Suicide Severity Rating Scale Baseline ( ) Draft Columbia-Suicide Severity Rating Scale Baseline ( ) Released Columbia-Suicide Severity Rating Scale Baseline ( ) Revised: QSSCAT added to be compatible with all CSSR-S questionnaires QSTPT replaced with QNAM=EVLINTTX to be compatible with all CSSR-S questionnaires using evaluation intervals Corrected Dose not apply, associated with the Most Severe Ideation,

2 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) Reasons on page 9 to Does not apply. Added QS terminology reference 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 2

3 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) 1 Introduction This document describes the CDISC implementation of the Baseline questionnaire, a standard questionnaire administered on a CRF that is typically used in clinical trials to identify subjects at risk for suicidal ideation and behavior. The CRF preceded the CDISC CDASH CRF standards and based on its copyright status, cannot be modified to CDASH standards. The representation of data collected for this questionnaire is based on the Study Data Tabulation Model Implementation Guide (SDTMIG) QS domain table, which can be found at the CDISC website at: ( These specific implementation details for this specific questionnaire are meant to be used in conjunction with the SDTMIG, but are recorded separately since this questionnaire may be used in many different therapeutic area implementations. All questionnaire documentation can be found on the CDISC web site at: ( The CDISC Intellectual Property Policy can be found on the CDISC web site at: ( 1.1 Representations and Warranties, Limitations of Liability, and Disclaimers This document is a supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials and is covered under Appendix F of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix F of the SDTMIG for a complete version of this material. 2 Copyright Status CDISC has obtained permission to include the Baseline questionnaire as part of CDISC Data Standards. This means that CDISC developed QSTESTCD and QSTEST for each question based on the actual question text on the questionnaire. The instrument itself was not changed. The CDISC documentation of this instrument consists of: (1) controlled terminology, (2) standard database structure with examples and (3) case report forms annotated with the CDISC SDTMIG submission values. Note: CDISC controlled terminology is maintained by NCI EVS. The most recent version should be accessed through the CDISC website. ( CDISC has developed this documentation at no cost to copyright holder or any additional cost to users of the instrument beyond the normal licenses fees charged by the copyright holder. CDISC acknowledges Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 3

4 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) Foundation for Mental Hygiene, Inc. for the agreement to include the Columbia-Suicidality Severity Rating Scale () baseline version scale in the CDISC data standards. The copyright owner s consent ensures that the data captured using this instrument will be done so in a standardized manner thereby facilitating collection, database storage, reporting and regulatory review of that data. CDISC wants to emphasize that the existing copyright status as well as the existing procedures for licensing fees and using the instrument will remain exactly as they have been. Please follow the instrument owners own mechanisms for permissions and licenses if you have a need to use this questionnaire. 3 The QS Domain Model 3.1 Assumptions for Questionnaire Domain Model All assumptions for the QS domain from the SDTMIG apply for this supplemental implementation guide including those referenced in the CDISC notes. Additionally, the following assumptions apply to the Columbia-Suicide Severity Rating Scale Baseline Form: 1. Columbia-Suicide Severity Rating Scale Baseline Form ( ): C- SSRS Baseline is a suicidal ideation rating scale. It rates an individual's degree of suicidal ideation on a scale, ranging from "wish to be dead" to "active suicidal ideation with specific plan and intent." 2. The time period of evaluation is populated in the QSEVLINT field in ISO 8601 format when the evaluation interval can be precisely described as duration. Specific points in time should use the QSDTC field. In cases where the evaluation interval cannot be precisely described as an ISO 8601 duration, the evaluation period should be represented using the Supplemental Qualifier QNAM=EVLINTTX. 3. The evaluator of the questionnaire is stored in QSEVAL and for the form the INVESTIGATOR provides the evaluation. 4. Terminology: a. QSCAT, QSTESTCD and QSTEST are approved CDISC controlled terminology. b. A full list of value sets for QSSCAT, QSORRES, QSSTRESC and QSSTRESN fields is provided in Section 4: Mapping Strategy. 3.2 Example for Columbia-Suicide Severity Rating Scale Baseline Domain Model The Baseline example below shows the terminology used to implement the questionnaire in the QS domain. The evaluation interval for this questionnaire is over the lifetime of the subject and is represented in SUPPQS with QNAM=EVLINTTX Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 4

5 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) Example: Columbia-Suicide Severity Rating Scale Baseline ( Baseline) This example shows data from one subject collected at one visit for a Baseline questionnaire. The example uses controlled terminology for QSTESTCD, QSTEST, QSCAT and QSSORRES for the measure. Rows 1-39: Represent the questions from the Form. All original results are represented with the standard values in QSORRES. This result is then transformed into a Standard Numeric score in QSSTRESN. Row 8, 10 and 27 are for illustrative purposes in order to display the QSTESTCD/QSTEST values and contain the value of XXX, the actual missing record would not be created in the QS domain qs.xpt Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSSCAT QSEVAL VISITNUM CSS01-Wish to 1 STUDYX QS 1 CSS0101 Yes Y INVESTIGATOR 1 be Dead CSS01-Wish to 2 STUDYX QS 2 CSS0101A be Dead, Wish dead Wish dead INVESTIGATOR 1 Describe 3 STUDYX QS 4 STUDYX QS 5 STUDYX QS 6 STUDYX QS 3 CSS CSS0102A 5 CSS CSS0103A CSS01-Non- Specific Suicidal Thought CSS01-Non- Specific Suicid Thought, Descr CSS01-Suicidal Ideation-No Intent CSS01-Suicidal Ideation-No Intent, Descr Yes Y INVESTIGATOR 1 I have thought about killing myself I have thought about killing myself INVESTIGATOR 1 Yes Y INVESTIGATOR 1 I thought about taking an overdose but I never made a specific plan I thought about taking an overdose but I never made a specific plan INVESTIGATOR 1 7 STUDYX QS 8 STUDYX QS 9 STUDYX QS 10 STUDYX QS 11 STUDYX QS 12 STUDYX QS 7 CSS CSS0104A 9 CSS CSS0105A 11 CSS CSS0106A CSS01-Ideation With Intent, No Plan CSS01-Ideation With Intent No Plan Descr CSS01-Ideation With Plan/Intent CSS01-Ideation With Plan/Intent, Descr Severe Ideation Severe Ideation, Description No N INVESTIGATOR 1 XXX INVESTIGATOR 1 No N INVESTIGATOR 1 XXX INVESTIGATOR INVESTIGATOR 1 Some intent to act on suicidal thoughts Some intent to act on suicidal thoughts INVESTIGATOR Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 5

6 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSSCAT QSEVAL VISITNUM 2-5 times in 13 STUDYX QS 13 CSS0107 Severe Ideation, 3 3 INVESTIGATOR 1 week Frequency 14 STUDYX QS 15 STUDYX QS 16 STUDYX QS 17 STUDYX QS 14 CSS CSS CSS CSS0111 Severe Ideation, Duration Severe Ideation, Control Severe Ideation, Deterrents Severe Ideation, Reasons Less than 1 hour/some of the time Can control thoughts with a lot of difficulty Deterrents definitely did not stop you Mostly to get attention, revenge or a reaction from others 2 2 INVESTIGATOR INVESTIGATOR INVESTIGATOR INVESTIGATOR 1 CSS01-Actual 18 STUDYX QS 18 CSS0112 Attempt Yes Y INVESTIGATOR 1 19 STUDYX QS CSS01-Number 19 CSS0113 of Actual Attempts INVESTIGATOR 1 20 STUDYX QS CSS01-Actual Try to get Try to get 20 CSS0113A Attempt, injured to get injured to get Describe attention attention INVESTIGATOR 1 21 STUDYX QS CSS01-Nonsuicidal Self- 21 CSS0114 injurious Behav Yes Y INVESTIGATOR 1 22 STUDYX QS CSS01-22 CSS0115 Interrupted Attempt Yes Y INVESTIGATOR 1 23 STUDYX QS CSS01-Number 23 CSS0116 of Interrupted Attempts INVESTIGATOR 1 CSS01-24 STUDYX QS Interrupted Stopped from Stopped from 24 CSS0116A Attempt, overdose overdose INVESTIGATOR 1 Describe 25 STUDYX QS CSS01-Aborted 25 CSS0117 Attempt No N INVESTIGATOR 1 26 STUDYX QS CSS01-Number 26 CSS0118 of Aborted Attempts INVESTIGATOR 1 27 STUDYX QS CSS01-Aborted 27 CSS0118A Attempt, Describe XXX INVESTIGATOR 1 28 STUDYX QS 28 CSS0119 CSS01- Yes Y INVESTIGATOR Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 6

7 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSSCAT QSEVAL VISITNUM Preparatory Acts/Behavior CSS01-29 STUDYX QS Preparatory 29 CSS0119A Acts/Behavior, Buying pills Buying pills INVESTIGATOR 1 Descr 30 STUDYX QS 31 STUDYX QS 32 STUDYX QS 33 STUDYX QS 34 STUDYX QS 35 STUDYX QS 36 STUDYX QS 37 STUDYX QS 38 STUDYX QS 39 STUDYX QS 30 CSS CSS0121A 32 CSS0121B 33 CSS0121C 34 CSS0122A 35 CSS0122B 36 CSS0122C 37 CSS0123A 38 CSS0123B 39 CSS0123C CSS01-Suicidal Behavior Recent Attempt Date Recent Attempt Damage Recent Attempt Potential Lethal Attempt Date Lethal Attempt Damage Lethal Attempt Potential CSS01-First Attempt Date CSS01-First Attempt Damage CSS01-First Attempt Potential No N INVESTIGATOR INVESTIGATOR 1 Minor physical damage Behavior likely to result in injury but not likely to cause death 1 1 INVESTIGATOR INVESTIGATOR INVESTIGATOR 1 Severe physical damage ehavior likely to result in death despite available medical care 4 4 INVESTIGATOR INVESTIGATOR INVESTIGATOR 1 No physical damage or very minor physical damage Behavior likely to result in injury but not likely to cause death 0 0 INVESTIGATOR INVESTIGATOR Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 7

8 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) The evaluation interval text value for data collection needs to be populated in SUPPQS as follows. The standard values for QNAM and QLABEL are listed below. suppqs.xpt STUDYID RDOMAIN USUBJID IDVAR IDVARVAL QNAM QLABEL QVAL QORIG QEVAL STUDYX QS VISITNUM 1 EVLINTTX Evaluation Interval Text LIFETIME CRF 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 8

9 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) 4 SDTM Mapping Strategy Baseline specific mapping strategy: This section is used for reference with the annotated CRF for further details on the CRF data capture and to understand the alignment of the questionnaire to the SDTM QS domain. It also provides guidance on how the result variables (QSORRES, QSORRESU, QSSTRESC, QSSTRESN, and QSSTRESU) should be populated for each questionnaire. If a result variable is not included in the table for a questionnaire, it should not be populated. QSSCAT QSTESTCD CSS0101 CSS0105A CSS0106 CSS0111 CSS0112 CSS0123C QSTESTCD= CSS0101 CSS0105 Ideation With Plan/Intent QSORRES Yes No QSTEST= CSS01-Wish to be Dead CSS01- QSSTRESC Y N QSTESTCD= CSS0106 QSTEST= Severe Ideation QSTESTCD= CSS0107 QSTEST= Severe Ideation, Frequency Less than once a week 1 1 Once a week times in week 3 3 Daily or almost daily 4 4 Many times each day 5 5 QSTESTCD= CSS0108 QSTEST= Severe Ideation, Duration Fleeting few seconds or minutes 1 1 Less than 1 hour/some of the time hours/a lot of time hours/most of day Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 9

10 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) More than 8 hours/persistent or continuous 5 5 QSTESTCD= CSS0109 QSTEST= Severe Ideation, Control Easily able to control thoughts 1 1 Can control thoughts with little difficulty 2 2 Can control thoughts with some difficulty 3 3 Can control thoughts with a lot of difficulty 4 4 Unable to control thoughts 5 5 Does not attempt to control thoughts 0 0 QSTESTCD= CSS0110 QSTEST= Severe Ideation, Deterrents Deterrents definitely stopped you from attempting suicide 1 1 Deterrents probably stopped you 2 2 Uncertain that deterrents stopped you 3 3 Deterrents most likely did not stop you 4 4 Deterrents definitely did not stop you 5 5 Does not apply 0 0 QSTESTCD= CSS0111 QSTEST= Severe Ideation, Reasons Completely to get attention, revenge or a reaction from others 1 1 Mostly to get attention, revenge or a reaction from others 2 2 Equally to get attention, revenge or a reaction from others and to end/stop the pain 3 3 Mostly to end or stop the pain 4 4 Completely to end or stop pain 5 5 Does not apply 0 0 QSTESTCD= CSS0112 CSS0120 Suicidal Behavior QSORRES Yes No QSTEST= CSS01-Actual Attempt CSS01- QSSTRESC Y N QSTESTCD= CSS0121B QSTEST= Recent Attempt Damage No physical damage or very minor physical damage 0 0 Minor physical damage Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 10

11 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) Moderate physical damage; medical attention needed 2 2 Moderately severe physical damage; medical hospitalization and likely intensive care required 3 3 Severe physical damage; medical hospitalization with intensive care required 4 4 Death 5 5 QSTESTCD= CSS0121C QSTEST= Recent Attempt Potential Behavior not likely to result in injury 0 0 Behavior likely to result in injury but not likely to cause death 1 1 Behavior likely to result in death despite available medical care 2 2 QSTESTCD= CSS0122B QSTEST= Lethal Attempt Damage No physical damage or very minor physical damage 0 0 Minor physical damage 1 1 Moderate physical damage; medical attention needed 2 2 Moderately severe physical damage; medical hospitalization and likely intensive care required 3 3 Severe physical damage; medical hospitalization with intensive care required 4 4 Death 5 5 QSTESTCD= CSS0122C QSTEST= Lethal Attempt Potential Behavior not likely to result in injury 0 0 Behavior likely to result in injury but not likely to cause death 1 1 Behavior likely to result in death despite available medical care 2 2 QSTESTCD= CSS0123B QSTEST= CSS01-First Attempt Damage No physical damage or very minor physical damage 0 0 Minor physical damage 1 1 Moderate physical damage; medical attention needed 2 2 Moderately severe physical damage; medical hospitalization and likely intensive care required 3 3 Severe physical damage; medical hospitalization with intensive care required 4 4 Death Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 11

12 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) QSTESTCD= CSS0123C QSTEST= CSS01-First Attempt Potential Behavior not likely to result in injury 0 0 Behavior likely to result in injury but not likely to cause death 1 1 Behavior likely to result in death despite available medical care Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 12

13 CDISC SDTM Baseline Questionnaire Supplement (Version 1.1) 5 Supplemental Qualifier Name Codes The following table contains additional standard name codes for use in the Supplemental Qualifiers for Questionnaires (SUPPQS) special-purpose dataset. QNAM QLABEL Applicable Domains EVLINTTX Evaluation Interval Text QS End of Document 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 13

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE) Columbia-Suicide Severity Rating Scale Baseline ( ) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and Analgesic Clinical Trial

More information

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE) Columbia-Suicide Severity Rating Scale Baseline ( ) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and Analgesic Clinical Trial

More information

Short-Form McGill Pain Questionniare-2 (SHORT-FORM MPQ-2)

Short-Form McGill Pain Questionniare-2 (SHORT-FORM MPQ-2) Short-Form McGill Pain Questionniare-2 ( ) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and Analgesic Clinical Trial Translations,

More information

Pain Relief (PR) Notes to Readers

Pain Relief (PR) Notes to Readers Pain (PR) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and Analgesic Clinical Trial Translations, Innovations, Opportunities,

More information

Disability Assessment for Dementia (DAD)

Disability Assessment for Dementia (DAD) Disability Assessment for Dementia (DAD) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CAMD AD v1.1 Team and the CDISC Questionnaire

More information

Epworth Sleepiness Scale (ESS)

Epworth Sleepiness Scale (ESS) Epworth Sleepiness Scale (ESS) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC Questionnaires Sub-team Notes to Readers This

More information

Clinical Global Impression (CGI)

Clinical Global Impression (CGI) Clinical Global Impression (CGI) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and Analgesic Clinical Trial Translations,

More information

Neuropathic Pain Scale (NPS)

Neuropathic Pain Scale (NPS) Neuropathic Pain Scale (NPS) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by Business & Decision Life Sciences and the CDISC Questionnaire

More information

Hospital Anxiety and Depression Scale (HADS)

Hospital Anxiety and Depression Scale (HADS) Hospital Anxiety and Depression Scale (HADS) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by Business & Decision Life Sciences and

More information

Modified Hachinski Ischemic Scale: NACC Version (MHIS-NACC) v.1.0

Modified Hachinski Ischemic Scale: NACC Version (MHIS-NACC) v.1.0 Modified Hachinski Ischemic Scale: NACC Version (MHIS-NACC) v.1.0 Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CAMD AD v2.0 Team

More information

Michigan Neuropathy Screening Instrument (MNSI)

Michigan Neuropathy Screening Instrument (MNSI) Michigan Neuropathy Screening Instrument () Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and Analgesic Clinical Trial Translations,

More information

Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Brief Psychiatric Rating Scale-Anchored (BPRS-A) Brief Psychiatric Rating Scale-Anchored (BPRS-A) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC Questionnaire Sub-team Notes

More information

Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Brief Psychiatric Rating Scale-Anchored (BPRS-A) Brief Psychiatric Rating Scale-Anchored (BPRS-A) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC Questionnaire Sub-team Notes

More information

Barnes Akathisia Rating Scale (BARS)

Barnes Akathisia Rating Scale (BARS) Barnes Akathisia Rating Scale () Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC Questionnaire Sub-team Notes to Readers This

More information

Hamilton Depression Rating Scale 17-Item (HAMD 17)

Hamilton Depression Rating Scale 17-Item (HAMD 17) Hamilton Depression Rating Scale -Item ( ) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and Analgesic Clinical Trial Translations,

More information

Timed Up and Go (TUG)

Timed Up and Go (TUG) Timed Up and Go (TUG) Functional Test Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by Multiple Sclerosis Outcomes Assessment Consortium and the

More information

Unified Parkinson's Disease Rating Scale UPDRS

Unified Parkinson's Disease Rating Scale UPDRS Unified Parkinson's Disease Rating Scale Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and National Institute of Neurological

More information

Unified Parkinson's Disease Rating Scale UPDRS

Unified Parkinson's Disease Rating Scale UPDRS Unified Parkinson's Disease Rating Scale Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and National Institute of Neurological

More information

With additional support from Florida International University and The Children s Trust.

With additional support from Florida International University and The Children s Trust. The Society for Clinical Child and Adolescent Psychology (SCCAP): Initiative for Dissemination of Evidence-based Treatments for Childhood and Adolescent Mental Health Problems With additional support from

More information

Let s Create Standard Value Level Metadata

Let s Create Standard Value Level Metadata PRA Health Sciences PhUSE US Connect 2019 Paper DS12 February 27, 2019 David Fielding Value Level Metadata Value Level Metadata is an important part of the Define-XML that allows us to explain our study

More information

Alzheimer s Disease-specific Therapeutic Area Supplement to the Study Data Tabulation Model User Guide

Alzheimer s Disease-specific Therapeutic Area Supplement to the Study Data Tabulation Model User Guide CDISC Alzheimer s disease SDTM User Guide (Version 1.0) Alzheimer s Disease-specific Therapeutic Area Supplement to the Study Data Tabulation Model User Guide Prepared by the Coalition Against Major Diseases

More information

Screening for Depression and Suicide Risk Assessment

Screening for Depression and Suicide Risk Assessment Screening for Depression and Suicide Risk Assessment Karl Rosston, LCSW Suicide Prevention Coordinator (406) 444-3349 krosston@mt.gov Updated: July, 2017 Suicide Fact Sheet Center for Disease Control WISQARS

More information

PharmaSUG Paper DS04

PharmaSUG Paper DS04 PharmaSUG2014 - Paper DS04 Considerations in the Submission of Exposure Data in SDTM-Based Datasets Fred Wood, Accenture Life Sciences, Wayne, PA Jerry Salyers, Accenture Life Sciences, Wayne, PA Richard

More information

ECZTRA 3. Efficacy Assessment & C-SSRS Manual

ECZTRA 3. Efficacy Assessment & C-SSRS Manual ECZTRA 3 Efficacy Assessment & C-SSRS Manual LP0162 1339 Efficacy Assement & C SSRS Manual, v 1.0, 25 Jan 2018 Efficacy Assessments General instruction Investigator assessments should be performed after

More information

CDISC BrCa TAUG & Oncology Information Session

CDISC BrCa TAUG & Oncology Information Session 1 15 September 2016 CDISC BrCa TAUG & Oncology Information Session Barrie Nelson @ DCDISC 2 24 February 2016 10:00-11:30am CST CDISC Oncology Information Session Rhonda Facile, Ann White, John Owen, Diane

More information

PharmaSUG Paper DS12

PharmaSUG Paper DS12 PharmaSUG 2017 - Paper DS12 Considerations and Conventions in the Submission of the SDTM Tumor and Response Domains Jerry Salyers, Accenture Accelerated R&D Services, Berwyn, PA Fred Wood, Accenture Accelerated

More information

Therapeutic Area User Guide Cardiovascular V1.0 Public Review Webinar April 3, 2014

Therapeutic Area User Guide Cardiovascular V1.0 Public Review Webinar April 3, 2014 Therapeutic Area User Guide Cardiovascular V1.0 Public Review Webinar April 3, 2014 1 Therapeutic Area User Guide CV V1.0 Public Review Webinar April 3, 2014 James Tcheng, MD, FACC, DCRI Steve Kopko, CDISC,

More information

SDTMIG v3.3 Batch 2 Upcoming Public Review. Presented by Fred Wood

SDTMIG v3.3 Batch 2 Upcoming Public Review. Presented by Fred Wood 1 SDTMIG v3.3 Batch 2 Upcoming Public Review Presented by Fred Wood 2 SDTMIG v3.3 Batch 2? What This package constitutes Batch 2 for the planned SDTMIG v3.3. It is planned to be available for a public

More information

Intervention ML: Mapping of Meal data. Rahul Loharkar, inventiv Health Clinical, Pune, India Sandeep Sawant, inventiv Health Clinical, Mumbai, India

Intervention ML: Mapping of Meal data. Rahul Loharkar, inventiv Health Clinical, Pune, India Sandeep Sawant, inventiv Health Clinical, Mumbai, India Paper DS06 Intervention ML: Mapping of Meal data. Rahul Loharkar, inventiv Health Clinical, Pune, India Sandeep Sawant, inventiv Health Clinical, Mumbai, India ABSTRACT The focus of most bioavailability/bioequivalence

More information

Jerry Salyers, Accenture Accelerated R&D Services Fred Wood, Accenture Accelerated R&D Services. PhUSE 2017 Edinburgh, Scotland Paper #DS05

Jerry Salyers, Accenture Accelerated R&D Services Fred Wood, Accenture Accelerated R&D Services. PhUSE 2017 Edinburgh, Scotland Paper #DS05 Jerry Salyers, Accenture Accelerated R&D Services Fred Wood, Accenture Accelerated R&D Services PhUSE 2017 Paper #DS05 } Review of Tumor domains and representative CRFs Ø TU (Tumor Identification) Ø TR

More information

Project Charter. Template v2 June 3, February 25, Name of Project: Prostate Cancer (PrCa) Therapeutic Area Data Standards

Project Charter. Template v2 June 3, February 25, Name of Project: Prostate Cancer (PrCa) Therapeutic Area Data Standards Project Charter Template v2 June 3, 2015 Name of Project: Prostate Cancer (PrCa) Therapeutic Area Data Standards February 25, 2016 Project Manager: John Owen 1. Scope of Prostate Cancer Therapeutic Area

More information

Methodological approach to the use and interpretation of baseline history of suicidal ideation and behavior Sarah DuBrava Pfizer, Inc

Methodological approach to the use and interpretation of baseline history of suicidal ideation and behavior Sarah DuBrava Pfizer, Inc Methodological approach to the use and interpretation of baseline history of suicidal ideation and behavior Sarah DuBrava Pfizer, Inc 2010 FDA Guidance In general, suicidality assessments should be conducted

More information

C-SSRS/KIT version includes. C-SSRS Scoring/ Administration instructions (13pgs)

C-SSRS/KIT version includes. C-SSRS Scoring/ Administration instructions (13pgs) This is a Sample version of the Columbia-Suicide Severity Rating Scale (C-SSRS) KIT The full version of watermark.. the C-SSRS/KIT comes without sample The full complete C-SSRS/KIT version includes C -SSRS

More information

Examples: Tables. Descriptive stats with ANOVA, ANCOVA, and t test p values Frequency and percent Correlation coefficients

Examples: Tables. Descriptive stats with ANOVA, ANCOVA, and t test p values Frequency and percent Correlation coefficients Examples: Tables Descriptive stats with ANOVA, ANCOVA, and t test p values Frequency and percent Correlation coefficients Descriptive Statistics Table 1. Body Mass Index using Last Observation Carried

More information

CFAST Asthma Project. Rhonda Facile. CDISC International Interchange Session 4B: Therapeutic Area Standards in Action November 6, 2013

CFAST Asthma Project. Rhonda Facile. CDISC International Interchange Session 4B: Therapeutic Area Standards in Action November 6, 2013 CFAST Asthma Project Rhonda Facile CDISC International Interchange Session 4B: Therapeutic Area Standards in Action November 6, 2013 1 Asthma Project CFAST Development Principles Asthma Background What

More information

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

LOUDOUN COUNTY PUBLIC SCHOOLS Department of Pupil Services. Suicide Prevention Guidelines

LOUDOUN COUNTY PUBLIC SCHOOLS Department of Pupil Services. Suicide Prevention Guidelines LOUDOUN COUNTY PUBLIC SCHOOLS Department of Pupil Services Suicide Prevention Guidelines 2016-2017 PREFACE As part of a comprehensive approach to suicide prevention, Loudoun County Public Schools (LCPS)

More information

How to manage changes to CDISC standards at Novo Nordisk. PhUSE EU Connect 2018 Sune Dandanell and Mikkel Traun

How to manage changes to CDISC standards at Novo Nordisk. PhUSE EU Connect 2018 Sune Dandanell and Mikkel Traun How to manage changes to CDISC standards at Novo Nordisk PhUSE EU Connect 2018 Sune Dandanell and Mikkel Traun How to manage changes to CDISC standards at Novo Nordisk 06-Nov-2018 2 How to manage changes

More information

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION:

More information

BUILDING BARRIERS TO SUICIDE:

BUILDING BARRIERS TO SUICIDE: BUILDING BARRIERS TO SUICIDE: Mr. F 78 yo male CAD, HTN, CABGx5 Depression? PCP of course you re depressed, your old Sig for anti depressant

More information

Therapeutic Area Data Standards User Guide for Cardiovascular Studies Version 1.0 (Provisional) Prepared by the CFAST Cardiovascular Team

Therapeutic Area Data Standards User Guide for Cardiovascular Studies Version 1.0 (Provisional) Prepared by the CFAST Cardiovascular Team Therapeutic Area Data Standards User Guide for Cardiovascular Studies Version 1.0 (Provisional) Prepared by the CFAST Cardiovascular Team Notes to Readers This is the provisional version 1.0 of the Therapeutic

More information

The Standard for the Exchange of Nonclinical Data (SEND): History, Basics, and Comparisons with Clinical Data

The Standard for the Exchange of Nonclinical Data (SEND): History, Basics, and Comparisons with Clinical Data Life Sciences Accelerated R&D Services The Science of Getting Products to Patients Faster The Standard for the Exchange of Nonclinical Data (SEND): History, Basics, and Comparisons with Clinical Data Fred

More information

Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface PREV-7 (NQF 0041): Preventive Care and Screening: Influenza Immunization Measure Steward: PCPI CMS Web Interface V2.1 Page 1 of 19 06/25/ Contents INTRODUCTION... 3 CMS WEB INTERFACE

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Measure #109: Osteoarthritis (OA): Function and Pain Assessment National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Quality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination

Quality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination Quality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: All patients

More information

CDISC - Mapping New Pathways for Novartis. Darren Weston, Project Leader Pat Majcher, Senior Principal Programmer

CDISC - Mapping New Pathways for Novartis. Darren Weston, Project Leader Pat Majcher, Senior Principal Programmer CDISC - Mapping New Pathways for Novartis Darren Weston, Project Leader Pat Majcher, Senior Principal Programmer Shuhong hong Xie, Senior Statistical Programmer Agenda What was the submission request?

More information

Clinical Trial Database Analyses to Inform Regulatory Guidances Suicidal Ideation and Behavior Assessment

Clinical Trial Database Analyses to Inform Regulatory Guidances Suicidal Ideation and Behavior Assessment Clinical Trial Database Analyses to Inform Regulatory Guidances Suicidal Ideation and Behavior Assessment Jean Kim, MD, MA Medical Officer Division of Psychiatry Products Office of New Drugs Center for

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient Reported Outcome High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient Reported Outcome High Priority Quality ID #220 (NQF 0425): Functional Status Change for Patients with Low Back Impairments National Quality Strategy Domain: Communication and Care Coordination Meaningful Measure Area: Patient Reported

More information

**Please read the DQA Measures User Guide prior to implementing this measure.**

**Please read the DQA Measures User Guide prior to implementing this measure.** **Please read the DQA Measures User Guide prior to implementing this measure.** DQA Measure Technical Specifications: Administrative Claims-Based Measures Prevention: Sealants for 6 9 year-old Children

More information

Breast Cancer TAUG Overview and Implementation

Breast Cancer TAUG Overview and Implementation Breast Cancer TAUG Overview and Implementation Anita Umesh, Ph.D. Senior Scientist, Enterprise Informatics Illumina, Inc. Bay Area CDISC User Group 9 December 2015 2014 Illumina, Inc. All rights reserved.

More information

Global Harmonization Task Force SG3 Comments and Recommendations ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO and 13488

Global Harmonization Task Force SG3 Comments and Recommendations ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO and 13488 Page 1 of 6 Global Harmonization Task Force SG3 ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO 13485 and 13488 GENERAL COMMENTS The Global Harmonization Task Force Study Group Three (GHTF

More information

How to - Trial Summary Parameter. CJUG SDTM Team : LISaS

How to - Trial Summary Parameter. CJUG SDTM Team : LISaS How to - Trial Summary Parameter CJUG SDTM Team : LISaS 2013-11-08 Preconditions for the Discussion CDISC Controlled Terminology: As of 2013-10-04 SDTM IG: v3.1.3 or v3.1.2 CDISC Protocol Representation

More information

Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE

More information

2019 CMS Web Interface

2019 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA CMS Web Interface V3.0 Page 1 of 18 xx/xx/2018 Contents INTRODUCTION... 3 CMS WEB INTERFACE SAMPLING INFORMATION... 4

More information

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #185 (NQF 0659): Colonoscopy Interval for Patients with a History of Adenomatous Polyps Avoidance of Inappropriate Use National Quality Strategy Domain: Communication and Care Coordination 2018

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface PREV-7 (NQF 0041): Preventive Care and Screening: Influenza Immunization Measure Steward: PCPI CMS Web Interface V2.0 Page 1 of 19 11/13/2017 Contents INTRODUCTION... 3 CMS WEB INTERFACE

More information

Suicide Prevention: From a Pharmacist s Perspective. Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service

Suicide Prevention: From a Pharmacist s Perspective. Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service Suicide Prevention: From a Pharmacist s Perspective Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service CPE Information and Disclosures Daina L. Wells declare(s) no conflicts of interest,

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process Measure #226 (NQF 0028): Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention National Quality Strategy Domain: Community / Population Health 2017 OPTIONS FOR INDIVIDUAL MEASURES:

More information

ISCTM SIB Consensus Statements for the Nomenclature & Classification Working Group

ISCTM SIB Consensus Statements for the Nomenclature & Classification Working Group ISCTM SIB Consensus Statements for the Nomenclature & Classification Working Group Members of the Nomenclature & Classification Working Group: Mort Silverman, Chair; Phil Chappell, Co-Chair; Lisa Brenner,

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient Reported Outcome High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient Reported Outcome High Priority Quality ID #223 (NQF 0428): Functional Status Change for Patients with General Orthopedic Impairments National Quality Strategy Domain: Communication and Care Coordination Meaningful Measure Area: Patient

More information

Clinical Review Report (Sample)

Clinical Review Report (Sample) CADTH COMMON DRUG REVIEW Clinical Review Report (Sample) GENERIC DRUG NAME (BRAND NAME) (Manufacturer) Indication: Text Disclaimer: The information in this document is intended to help Canadian health

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process Measure. #185 (NQF 0659): Colonoscopy Interval for Patients with a History of Adenomatous Polyps Avoidance of Inappropriate Use National Quality Strategy Domain: Communication and Care Coordination 2017

More information

DENOMINATOR: All patients 18 and older prescribed opiates for longer than six weeks duration

DENOMINATOR: All patients 18 and older prescribed opiates for longer than six weeks duration Quality ID #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Prevention and Treatment of Opioid and Substance Use

More information

Suicide Prevention and Intervention

Suicide Prevention and Intervention Suicide Prevention and Intervention Kim Myers, MSW May 2, 2017 Division of Substance Abuse and Mental Health Overview Suicide in Utah Suicide Risk & Protective Factors Suicide Warning Signs C-SSRS Safety

More information

Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety

Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Outcome DESCRIPTION:

More information

Quality ID #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination

Quality ID #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination Quality ID #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Outcome DESCRIPTION: Pathology

More information

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign Quality ID #146 (NQF 0508): Radiology: Inappropriate Use of Probably Benign Assessment Category in Screening Mammograms National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS F INDIVIDUAL

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Quality ID #432: Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Measure #389: Cataract Surgery: Difference Between Planned and Final Refraction - National Quality Strategy Domain: Effective Clinical Care

Measure #389: Cataract Surgery: Difference Between Planned and Final Refraction - National Quality Strategy Domain: Effective Clinical Care Measure #389: Cataract Surgery: Difference Between Planned and Final Refraction - National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:

More information

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:

More information

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period Measure #48: Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA CMS Web Interface V2.1 Page 1 of 18 06/25/ Contents INTRODUCTION... 3 CMS WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic Conditions 2019 COLLECTION

More information

Design and Construct Efficacy Analysis Datasets in Late Phase Oncology Studies

Design and Construct Efficacy Analysis Datasets in Late Phase Oncology Studies PharmaSUG China Design and Construct Efficacy Analysis s in Late Phase Oncology Studies Huadan Li, MSD R&D (China) Co., Ltd., Beijing, China Changhong Shi, MSD R&D (China) Co., Ltd., Beijing, China ABSTRACT

More information

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period Quality ID #48: Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface CARE-2 (NQF 0101): Falls: Screening for Future Fall Risk Measure Steward: NCQA CMS Web Interface V2.1 Page 1 of 18 12/11/2017 Contents INTRODUCTION... 3 CMS WEB INTERFACE SAMPLING INFORMATION...

More information

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge. Quality ID #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) National Quality

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Measure #143 (NQF 0384): Oncology: Medical and Radiation Pain Intensity Quantified National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2017 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:

More information

Suicide Prevention & The Art of Asking: Bridging Clinical Assessment and Community Conversations to Promote Awareness and Prevention

Suicide Prevention & The Art of Asking: Bridging Clinical Assessment and Community Conversations to Promote Awareness and Prevention Suicide Prevention & The Art of Asking: Bridging Clinical Assessment and Community Conversations to Promote Awareness and Prevention Introductions Daniel Schwarz, Ph.D. Daniel Schwarz, Ph.D. Anna Trout,

More information

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Measure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care

Measure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care Measure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND

GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND 48+ MONTHS DECEMBER 2017 Guidance For Sampling ART

More information

CDISC Public Webinar- Huntington's Disease Therapeutic Area User Guide

CDISC Public Webinar- Huntington's Disease Therapeutic Area User Guide CDISC Public Webinar- Huntington's Disease Therapeutic Area User Guide 12 September 2017 Jon Neville CDISC Daniel Olson- Critical Path Institute (C-Path) 1 AGENDA Project Background Introduction to Huntington's

More information

DENOMINATOR: All patients aged 18 years and older seen for at least two visits or at least one preventive visit during the measurement period

DENOMINATOR: All patients aged 18 years and older seen for at least two visits or at least one preventive visit during the measurement period Quality ID #431 (NQF 2152): Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling - National Quality Strategy Domain: Community / Population Health 2018 OPTIONS F INDIVIDUAL

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Quality ID #177: Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity National Quality Strategy Domain: Effective Clinical Care Measure Meaningful Measure Area: Management of Chronic Conditions

More information

Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care

Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #134 (NQF 0418): Preventive Care and Screening: Screening for Depression and Follow-Up Plan National Quality Strategy Domain: Community/Population Health 2018 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process DESCRIPTION: Percentage of

More information

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction Measure #7 (NQF 0070): Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) National Quality Strategy Domain: Effective

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #322: Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #222 (NQF 0427): Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Elbow, Wrist or Hand Impairments National Quality Strategy Domain: Communication and Care Coordination

More information

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign Measure #146 (NQF 0508): Radiology: Inappropriate Use of Probably Benign Assessment Category in Screening Mammograms National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS F

More information

CDISC Public Webinar- Post Traumatic Stress Disorder Therapeutic Area User Guide

CDISC Public Webinar- Post Traumatic Stress Disorder Therapeutic Area User Guide CDISC Public Webinar- Post Traumatic Stress Disorder Therapeutic Area User Guide 26 September 2017 Allyson Gage Cohen Veterans Biosciences Amy Palmer CDISC Kathleen Mellars CDISC Dana Booth - CDISC 1 AGENDA

More information

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority Quality ID #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety Meaningful Measure Area: Admissions and Readmissions to Hospitals 2019 COLLECTION

More information